^
BIOMARKER:

ATM mutation

i
Other names: ATM, ATA, ATC, ATD, ATDC, TEL1, TELO1, ATM serine/threonine kinase
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
ATM mutation
Prostate Cancer
olaparib
Sensitive
:
A1
ATM mutation
Squamous Cell Carcinoma of Head and Neck
durvalumab + CP-675206
Sensitive
:
B
ATM mutation
Breast Cancer
ribociclib
Resistant
:
B
ATM mutation
Chronic Lymphocytic Leukemia
obinutuzumab
Resistant
:
B
ATM mutation
Ovarian Cancer
olaparib
Sensitive
:
B
ATM mutation
Solid Tumor
Immunotherapy
Sensitive
:
B
ATM mutation
Lung Adenocarcinoma
olaparib
Sensitive
:
C1
ATM mutation
Pancreatic Cancer
olaparib
Sensitive
:
C1
ATM mutation
Pancreatic Ductal Adenocarcinoma
olaparib
Sensitive
:
C1
ATM mutation
Urothelial Cancer
olaparib
Sensitive
:
C1
ATM mutation
Biliary Tract Cancer
olaparib
Sensitive
:
C1
ATM mutation
Solid Tumor
rucaparib
Sensitive
:
C2
ATM mutation
Solid Tumor
BAY 1895344
Sensitive
:
C2
ATM mutation
Prostate Cancer
talazoparib
Sensitive
:
C2
ATM mutation
HER2 Negative Breast Cancer
durvalumab
Sensitive
:
C2
ATM mutation
Solid Tumor
avelumab
Sensitive
:
C2
ATM mutation
Solid Tumor
APG-115
Sensitive
:
C2
ATM mutation
Biliary Tract Cancer
toripalimab
Resistant
:
C3
ATM mutation
Colorectal Cancer
niraparib
Sensitive
:
C3
ATM mutation
Gastroesophageal Junction Adenocarcinoma
Immunotherapy
Sensitive
:
C3
ATM mutation
Gastric Adenocarcinoma
Immunotherapy
Sensitive
:
C3
ATM mutation
Colon Cancer
Immunotherapy
Sensitive
:
C3
ATM mutation
Mantle Cell Lymphoma
venetoclax + ibrutinib
Sensitive
:
C3
ATM mutation
Squamous Cell Carcinoma of Head and Neck
durvalumab
Sensitive
:
C3
ATM mutation
Prostate Cancer
pembrolizumab
Sensitive
:
C3
ATM mutation
Prostate Cancer
GnRH stimulant
Resistant
:
C3
ATM mutation
Pancreatic Ductal Adenocarcinoma
durvalumab + gemcitabine + CP-675206
Sensitive
:
C3
ATM mutation
Prostate Cancer
avelumab
Sensitive
:
C3
ATM mutation
Ovarian Cancer
olaparib + AZD6738
Sensitive
:
C3
ATM mutation
Non Small Cell Lung Cancer
Immunotherapy
Sensitive
:
C3
ATM mutation
Gastrointestinal Cancer
rucaparib
Sensitive
:
C3
ATM mutation
Breast Cancer
CDK6 inhibitor
Resistant
:
C3